# Muhdo > Muhdo is a health technology company that provides genetic and epigenetic testing, personalized health insights, supplements, and AI-supported coaching through Muhdohub. - Canonical URL: https://iq.wiki/wiki/muhdo - Categories: Organizations - Tags: DataPlatform - Created: 2026-10-24T05:25:36.001Z - Last updated: 2026-10-24T05:25:36.001Z - Source: IQ.wiki — the world's largest blockchain and crypto encyclopedia (https://iq.wiki) --- **Muhdo** is a London-based health brand and personalized-health platform that combines genetic and epigenetic testing, an app, and supplements to provide health insights and support preventative wellness. Its digital service, Muhdohub, also presents a [Web3](https://iq.wiki/wiki/web3) model in which users interact through the DNA token and can be rewarded for sharing health data.[\[1\]](#cite-id-z922ciudbb)​[\[2\]](#cite-id-esx4d1tidi)​[\[3\]](#cite-id-c602zt2nbr)​ ## Overview Muhdo describes its goal as shifting healthcare from treating illness toward prevention through personalized, data-driven services. Its stated mission is to make premium healthcare affordable and help individuals measure, track, and optimize health at a cellular level.[\[4\]](#cite-id-q1qvmwovtm)​ The organization says its services use genetic and epigenetic profiling alongside artificial intelligence (AI) to develop personalized products and health guidance. It frames longevity as improving health and quality of life, rather than simply extending lifespan, and identifies chronic conditions including asthma, diabetes, obesity, and heart disease as concerns.[\[4\]](#cite-id-q1qvmwovtm)​[\[5\]](#cite-id-otkefcd6xd)​ ## Products and Services Muhdohub offers DNA and epigenetic test kits, supplements, and a health app. The company says its DNA tests analyze a user’s genetic makeup to generate personalized health insights, which can also inform supplement recommendations.[\[2\]](#cite-id-esx4d1tidi)​ The app includes MAISIE, an AI health coach described by Muhdo as available around the clock and intended to guide health decisions using a user’s genetic profile. Muhdohub also markets [Timeless](https://iq.wiki/wiki/timeless), a longevity supplement designed to target ageing, and says its supplements are formulated to work at the cellular level based on eight years of genetic and epigenetic research.[\[2\]](#cite-id-esx4d1tidi)​[\[4\]](#cite-id-q1qvmwovtm)​ ## Scientific Approach Muhdo explains epigenetics as the influence of lifestyle, environment, and daily choices on gene expression without changing a person’s DNA sequence. It describes DNA methylation as the attachment of methyl groups to DNA by DNA methyltransferase enzymes, a process that affects gene activity. The company distinguishes chronological age from biological age, which it characterizes as a measure of cellular ageing affected by factors such as diet, sleep, stress, exercise, and environment.[\[5\]](#cite-id-otkefcd6xd)​ Muhdo says its bioinformatics and science team has identified genes, biomarkers, and environmental triggers associated with ageing. It cites research indicating that epigenetics may influence up to 70% of long-term health outcomes, and presents genetic and epigenetic testing as a way to help users make lifestyle choices and reduce future health risks.[\[4\]](#cite-id-q1qvmwovtm)​ The company promotes a saliva-based epigenetic clock using 10 CpG sites, attributed to Collins, Brown, and Chung’s 2025 paper. Muhdo says the sites were identified with the Illumina EPIC 850k array and that the clock estimates biological age and the pace of DNA methylation. It describes the test as non-invasive and less costly to run than clocks using hundreds of markers, and reports a correlation of approximately _r_ = 0.80, with improved performance among very healthy subjects.[\[5\]](#cite-id-otkefcd6xd)​ ## Research and Partnerships Muhdo says that over the preceding eight years it collaborated or partnered with universities and institutions including King’s College London, the University of Oxford, the National University of Singapore, and the European Union. Its work with the EU’s Predictom project concerns scientific innovation and epigenetic research into Alzheimer’s disease; Muhdo cites a EUR 21 million investment in the PREDICTOM project to advance early Alzheimer’s detection.[\[5\]](#cite-id-otkefcd6xd)​ The company also describes a phase of the [Horizon](https://iq.wiki/wiki/horizon) Predictum partnership with King’s College London focused on depression, clinical trials, and epigenetics in mental health, as well as a King’s research project on epigenetics, AI, and informatics. Its other research references include an Oxford-developed, non-invasive haemolysis test for scalable early detection in blood health and diagnostics, and longevity research with the National University of Singapore.[\[5\]](#cite-id-otkefcd6xd)​ Muhdo says its epigenetic clock was featured on BBC Click at King’s College London and that it worked with Illumina, a DNA sequencing technology company, to support the precision and reliability of its genetic and epigenetic analyses.[\[5\]](#cite-id-otkefcd6xd)​ ## Tokenomics and Web3 Ecosystem Muhdohub describes a [Web3](https://iq.wiki/wiki/web3) ecosystem connecting DNA-based health insights, AI coaching, personalized supplements, and a token-powered model. Users earn and interact through the DNA token, also written as $DNA. The project describes [blockchain](https://iq.wiki/wiki/blockchain) as a means of managing health data securely and transparently, while its broader stated goal is to reward users for sharing data and make healthcare more accessible and trustworthy.[\[4\]](#cite-id-q1qvmwovtm)​[\[3\]](#cite-id-c602zt2nbr)​ Muhdo says that 30% of on-chain revenue funds token buybacks, [staking](https://iq.wiki/wiki/staking) rewards, and the MuhDAO. It presents this structure as part of an ecosystem designed around transparency, real-world utility, and community ownership.[\[4\]](#cite-id-q1qvmwovtm)​